Tim Kümmerle

3.9k citations

20 papers · 225 indexed · h-index 9

Impact in

Hepatology top 10%
- Hepatitis C virus research
Virology top 10%
- HIV Research and Treatment

Papers in ⓘ

Virology 5
- HIV Research and Treatment 4
Infectious Diseases 12
- HIV/AIDS Research and Interventions 7
- HIV/AIDS drug development and treatment 6

Co-authors: Christoph Wyen (9 shared papers)Jürgen K. Rockstroh (6 shared papers)Gerd Fätkenheuer (10 shared papers)Clara Lehmann (9 shared papers)Christoph Boesecke (8 shared papers)Martin Vogel (2 shared papers)Jörg Janne Vehreschild (5 shared papers)Oliver A. Cornely (5 shared papers)
Journals: Infection (5 papers)HIV Medicine (2 papers)Liver International (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Antiviral Therapy (1 paper)
Partner nations: Germany United States Australia

In The Last Decade

Tim Kümmerle

20 papers receiving 217 citations

Peers

Countries citing papers authored by Tim Kümmerle

Since Specialization

Citations

This map shows the geographic impact of Tim Kümmerle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Kümmerle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Kümmerle more than expected).

Fields of papers citing papers by Tim Kümmerle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Kümmerle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Kümmerle. The network helps show where Tim Kümmerle may publish in the future.

Co-authors

The 25 scholars most cited alongside Tim Kümmerle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim Kümmerle Line = papers co-authored together Tim Kümmerle links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pegylated Interferon-α for the Treatment of Sexually Transmitted Acute Hepatitis C in HIV-Infected Individuals Antiviral Therapy ·Martin Vogel, Jacob Nattermann, Axel Baumgarten, Gerd Klausen, B Bieniek, Knud Schewe, Heiko Jessen, Christoph Boesecke, Michael Rausch, Thomas A. Lutz, Stefan Fenske, Dietmar Schranz, Tim Kümmerle, Christoph Schuler, Albert Theisen, Christoph Mayr, Thomas Seidel, Jürgen K. Rockstroh	2006	52
2	Causes of death in HIV-infected patients from the Cologne–Bonn cohort Infection ·Kathrin Ehren, Ch. Hertenstein, Tim Kümmerle, Jörg Janne Vehreschild, Julia Fischer, Daniel Gillor, Christoph Wyen, Clara Lehmann, Oliver A. Cornely, Norma Jung, Sophia Gravemann, Martin Platten, J.‐C. Wasmuth, Jürgen K. Rockstroh, Christoph Boesecke, Carolynne Schwarze‐Zander, Gerd Fätkenheuer	2013	30
3	Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany Liver International ·Martin Vogel, Thijs van de Laar, Bernd Kupfer, Hans‐Jürgen Stellbrink, Tim Kümmerle, Stefan Mauss, Gaby Knecht, Annemarie Berger, Sylvia M. Bruisten, Jürgen K. Rockstroh	2010	29
4	Echocardiographic screening for pulmonary arterial hypertension in HIV-positive patients Infection ·Henrik ten Freyhaus, David H. V. Vogel, Clara Lehmann, Tim Kümmerle, Christoph Wyen, Gerd Fätkenheuer, Stephan Rosenkranz	2014	18
5	Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study Infection ·Christoph D. Spinner, Christoph Boesecke, Cornelius Jordan, Christoph Wyen, Tim Kümmerle, Gaby Knecht, Stefan Scholten, Alexander Zink, Ivanka Krznaric, Sebastian Noé	2018	16
6	Liver involvement in HIV-infected patients diagnosed with syphilis Infection ·Norma Jung, Tim Kümmerle, S. D. Brengelmann, Jörg Gielen, Clara Lehmann, Christoph Wyen, Andrea Birtel, Julia Fischer, Daniel Gillor, Sebastian Koch, Jörg Janne Vehreschild, Oliver A. Cornely, Gerd Fätkenheuer	2012	12
7	Anidulafungin – state of affairs from a clinical perspective Mycoses ·Jörg Janne Vehreschild, Tim Kümmerle, Meinolf Karthaus, Oliver A. Cornely	2007	11
8	Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany Epidemiology and Infection ·C Schwarze-Zander, Rika Draenert, Clara Lehmann, Melanie Stecher, Christoph Boesecke, Stefanie Sammet, JC Wasmuth, Ulrich Seybold, Daniel Gillor, Ulrike Wieland, Tim Kümmerle, C.P. Strassburg, Annette Mankertz, Anna Maria Eis‐Hübinger, Gundula Jäger, Gerd Fätkenheuer, Johannes R. Bogner, JK Rockstroh, Jörg Janne Vehreschild	2016	9
9	Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic Infection ·Martin Platten, Rachel W. Linnemann, Tim Kümmerle, Norma Jung, Christoph Wyen, Kathrin Ehren, Sophia Gravemann, Daniel Gillor, Oliver A. Cornely, Julia Fischer, Clara Lehmann, Jürgen K. Rockstroh, Gerd Fätkenheuer, Jörg Janne Vehreschild	2014	8
10	Pharmacokinetics of once-daily dolutegravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study Journal of Antimicrobial Chemotherapy ·Christoph D. Spinner, Tim Kümmerle, Ivanka Krznaric, Olaf Degen, Christiane Schwerdtfeger, Alexander Zink, Eva Wolf, Hartwig Klinker, Christoph Boesecke	2017	8
11	Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection Expert Opinion on Investigational Drugs ·Tim Kümmerle, Clara Lehmann, Pia Hartmann, Christoph Wyen, Gerd Fätkenheuer	2009	6
12	To prescribe, or not to prescribe: decision making in HIV‐1 post‐exposure prophylaxis HIV Medicine ·Merel Scholten, Isabelle Suárez, Martin Platten, Tim Kümmerle, Norma Jung, Christoph Wyen, Angela Ernst, Carola Horn, Volker Burst, Víctor Suárez, Jan Rybniker, Gerd Fätkenheuer, Clara Lehmann	2018	6
13	[Value of p53, urokinase plasminogen activator, PAI-1 and Ki-67 in vulvar carcinoma]. PubMed ·G. M. Hoffmann, F. Casper, W. Weikel, Tim Kümmerle, B Pollow, Michael Schaffrath, Marie‐Claude Hofmann, Kunibert Pollow	1999	4
14	Predictors of serofast state after treatment for early syphilis in HIV‐infected patients HIV Medicine ·Gregor Paul, Johanna Theresa Wesselmann, Dejan Adzic, Jakob J Malin, Isabelle Suárez, Vanessa Priesner, Tim Kümmerle, Christoph Wyen, Norma Jung, Kathrin van Bremen, Stefan Schlabe, J‐C Wasmuth, Christoph Boesecke, Gerd Fätkenheuer, JK Rockstroh, Carolynne Schwarze‐Zander, Clara Lehmann	2020	4
15	Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance AIDS Research and Therapy ·Eva Wolf, Christoph Boesecke, Annamaria Balogh, Helen Bidner, Christiane Cordes, Hans Heiken, Ivanka Krznaric, Tim Kümmerle, Hans‐Jürgen Stellbrink, Jochen Schneider, Christoph D. Spinner, (unknown)	2021	3
16	Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the cologne-bonn cohort European journal of medical research ·Benedict Steffens, Tim Kümmerle, Sven D. Koch, Andrea Birtel, Carolynne Schwarze‐Zander, J Emmelkamp, Werner Kern, Ch. Hertenstein, Christoph Wyen, Clara Lehmann, Oliver A. Cornely, Jürgen K. Rockstroh, Gerd Fätkenheuer	2011	3
17	Clinical and epidemiological characteristics of patients with early syphilis from three academic centres in Poland, Germany and Ireland: initial findings from the POETS study Sexually Transmitted Infections ·Dominic Rowley, Paweł Święcki, Ewa Firląg‐Burkacka, Caroline Sabin, Tim Kümmerle, S Surah, Corinna Sadlier, S O’Dea, A Horban, Gerd Fätkenheuer, F Mulcahy	2015	2
18	How successful is influenza vaccination in HIV infected patients? Results from an influenza A(H1N1)pdm09 vaccine study HIV & AIDS Review ·Carolynne Schwarze‐Zander, Benedict Steffens, J Emmelkamp, Tim Kümmerle, Christoph Boesecke, J C Wasmuth, C. P. Strassburg, Gerd Fätkenheuer, Jürgen K. Rockstroh, Anna Maria Eis‐Hübinger	2016	2
19	Switching to a NRTI-free 2 drug regimen (2DR) –a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes SHILAP Revista de lepidopterología ·Malte B. Monin, Tim Kümmerle, Jochen Schneider, Christiane Cordes, Hans Heiken, Hans‐Jürgen Stellbrink, Ivanka Krznaric, Stefan Scholten, Björn‐Erik Ole Jensen, Heiko Jessen, Wilfried Obst, Petra Spornraft‐Ragaller, Pavel Khaykin, Annamaria Balogh, Eva Wolf, Helen Bidner, Christoph D. Spinner, Christoph Boesecke, (unknown)	2022	1
20	Tollwut-Impfung: wann und wie? DMW - Deutsche Medizinische Wochenschrift ·Tim Kümmerle, Gerd Fätkenheuer, Michael Hallek	2012	1

About Tim Kümmerle

Tim Kümmerle is a scholar working on Virology, Infectious Diseases, Epidemiology, Microbiology and Emergency Medicine, having authored 20 papers that have together received 225 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (7 papers), HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Syphilis Diagnosis and Treatment (4 papers), HIV-related health complications and treatments (3 papers), Influenza Virus Research Studies (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Hepatology (87 citations), Virology (34 citations), Infectious Diseases (106 citations), Epidemiology (144 citations) and Microbiology (19 citations). Tim Kümmerle has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Christoph Wyen, Jürgen K. Rockstroh, Gerd Fätkenheuer, Clara Lehmann, Christoph Boesecke, Martin Vogel, Jörg Janne Vehreschild, Oliver A. Cornely, Gaby Knecht and Norma Jung. Their work appears in journals such as Infection, HIV Medicine, Liver International, Journal of Antimicrobial Chemotherapy and Antiviral Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact